TRANSPLANTATION PROCEEDINGS, cilt.49, sa.3, ss.467-471, 2017 (SCI-Expanded)
Background. Renal transplantation (RT) is the best treatment option for patients with end-stage renal disease (ESRD) because it improves both quality of life and survival. However, allograft rejection remains the most important barrier to successful transplantation. Underlying immunologic mechanisms should be understood to develop appropriate treatment strategies.